Recently, Kolmar Korea, a prominent supplier to global cosmetics brands such as Estee Lauder, announced the development of artificial intelligence (AI) technology designed to diagnose androgenic alopecia, a genetically determined hair disorder triggered by an excessive response to androgens. This innovative technology is capable of identifying 16 distinct types of androgenic alopecia, with nine variations in men and seven in women, by analyzing specific biomarkers (DNA) on the scalp surface.
The diagnostic process involves a cosmetics researcher scraping the consumer’s scalp to collect biomarkers. These samples are then placed into an analysis device connected to a sophisticated computer program. The program meticulously examines the biomarkers to determine the presence and type of androgenic alopecia.
Kolmar Korea aims to leverage this technology in collaboration with its client companies to develop bespoke cosmetics tailored to the 16 identified types of androgenic alopecia. “About 700 genetic mutations occur for each type of androgenic alopecia,” a company source explained. “We plan to recommend over 10,000 customized cosmetics based on the types of genetic mutations.” This advancement not only promises personalized treatment options for individuals suffering from androgenic alopecia but also marks a significant step forward in the integration of AI technology in the field of cosmetic dermatology.
